临床人群中的性饮食 - - 一个叙述性综述
Alon Zemer1, Shabnam Samaei2, Uri Yoel3
1Department of Pharmacology and Clinical Biochemistry, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Frontiers in medicine
|November 13, 2024
概括
素饮食 (KD) 是一种高脂肪,低碳水化合物饮食计划,有望减肥,改善健康标志物. 然而,长期安全问题和需要标准化临床指南的需要需要进一步的研究.
科学领域:
- 营养科学 营养科学
- 代谢健康 代谢健康
- 饮食干预 饮食干预
背景情况:
- 性饮食 (KD) 是一种高脂肪,低碳水化合物饮食方法,可诱导症,将新陈代谢转移到脂质利用.
- 凯迪越来越受欢迎用于各种健康状况,包括体重管理,神经系统疾病和癌症治疗.
- 尽管有报道的好处,但关于KD的长期安全性和潜在的健康风险存在重大争议.
研究的目的:
- 评估基因饮食对各种健康状况的疗效和安全性.
- 解决KD患者采用和临床接受之间的差距.
- 突出标准化KD协议和进一步研究的需要.
主要方法:
- 审查关于性饮食有效性和安全性的现有文献.
- 对临床观察和患者报告结果的分析.
- 确定有关KD的争议和研究缺口.
主要成果:
- 凯迪在减肥,血糖控制,认知功能和癌症预后方面表现出有效性.
- 经常报告患者的积极结果,导致广泛采用.
- 人们仍然担心长期的健康影响以及缺乏标准化的治疗方案.
结论:
- 临床医生应被告知KD,以支持自我选择这种饮食的患者.
- 进一步高质量的研究是建立长期安全性和标准化KD临床使用的必要条件.
- 对于KD患者来说,医疗监督至关重要,以确保健康的饮食选择并防止不良结果.
相关概念视频
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Diabetes: Management and Pharmacotherapy
236
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
236
Acute Pancreatitis II: Clinical Manifestations and Management
93
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
93
Chronic Pancreatitis II: Collaborative Care
70
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
70
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Overview of Carbohydrate Metabolism
753
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
753


